miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3. - Wikidata - wikimedia - TriplyDB

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

http://www.wikidata.org/entity/Q38871765

about

MicroRNAs, DNA Damage Response, and Cancer Treatment Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis miR-106a Is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B and Associated with Enhanced Levels of Interleukin-8.NSun2 Promotes Cell Growth via Elevating Cyclin-Dependent Kinase 1 Translation.C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer Hepatic stimulator substance resists hepatic ischemia-reperfusion injury by regulating Drp1 translocation and activation.Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway.Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer.miR-582-5p inhibits invasion and migration of salivary adenoid cystic carcinoma cells by targeting FOXC1.Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.

P2860

Q28067062-91D0EFA6-0ECD-4A84-AB53-DE7734597E2B Q33833557-69DC0207-6D0C-4CD8-B13C-C5069C959B04 Q35918746-23844F1A-9D6D-4436-983E-76F6BC1EC56B Q36234289-62FE0E69-93FC-46AB-8923-2221BF6201DB Q36587856-D9F61357-49EF-497A-83B5-F17774A9D398 Q38711036-258AC794-47CF-4EEA-9903-A8E0AD046909 Q40049662-342CBF05-C201-47E9-BCEE-F6E5ECBB004B Q42700916-1D5E99F4-0FE6-4496-AC1B-8BB53B2CC0A8 Q47108123-E0865957-F68A-4E85-B19E-161A2F72709B Q50596382-332C9320-6F5E-4AA1-BFEE-1F293027D6EE Q52586706-F865832C-A975-4CF8-9011-294AF45338BB

P2860

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

http://www.wikidata.org/entity/Q38871765

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

@en

type

label

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

@en

prefLabel

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

@en

P1433

Q38871765-B2D8E8AD-833C-4372-9805-85BED1323FE4

P1476

Q38871765-BC7190FB-11C4-41AD-9EEB-D062179F9166

P2093

Q38871765-6DFEAD0F-4FA1-4F86-AEDE-BD64FC44EEB1

Q38871765-7FBF446C-466E-42B8-8B8E-A06E325D99D8

Q38871765-9C7FFE01-034D-44DF-9D91-8D288C109EC6

Q38871765-AFF039D3-2EE5-4AF1-A3BF-F25196DA29B3

Q38871765-E151DFA4-BA08-4B5E-8A83-CF0B21FCF67B

Q38871765-EECA1CCD-1C16-499C-82A4-134E64FF1EA4

Q38871765-F4F4AE1A-03B1-4322-A5CC-30F272750CCA

Q38871765-FEFB8FAE-8345-49EE-B50F-3942D68D6C4B

P2860

Q38871765-09AEDA00-2C72-4007-9AA2-C9477387D245

Q38871765-11C30248-EEBA-40FD-9F44-1684656B2F00

Q38871765-15EB4F2D-3A6C-4E8F-8A98-E4D90D622698

Q38871765-178F62D0-1D80-4998-87F9-5F8FCABD1563

Q38871765-1C64C33A-D3C4-4108-AAC4-6F20F00735F0

Q38871765-1FB4A331-5560-4B3A-B1E0-7BE27877212D

Q38871765-25867496-3257-406F-88F7-C9E72049F757

Q38871765-28401901-1437-4E6B-A384-EBF10A663921

Q38871765-469A3F9A-9856-4F06-9EBA-F90900F8F624

Q38871765-475ED6F3-3297-4E42-BAD9-424E03CB6B35

P2888

Q38871765-42AEA62F-1322-4E25-A5B0-EC3735692E29

P304

Q38871765-4FD69A92-1903-4EEC-AFC5-326736A9BD00

P31

Q38871765-75F95D8E-76AF-4928-9B72-141465441DEC

P356

Q38871765-0AB279C3-6A31-4E97-A747-EC1474DF4CAB

P433

Q38871765-443EC676-5951-4B51-A2EA-D2E3645FEEE1

P478

Q38871765-DBA2B8AC-9764-440A-BCAE-21873C52F7A8

P577

Q38871765-E780C7A1-602D-49BB-86D8-8B43BD9ED5E4

P6179

Q38871765-D12408ED-CE5A-4C63-95E6-02F86B7424F4

P698

Q38871765-AD062A0D-C7C5-4B7B-AA2B-A784C61AC234

P356

S13277-015-3582-0

P1433

P1476

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.

@en

P2093

Qifa Ye

http://www.w3.org/2001/XMLSchema#string

Wei Huang

http://www.w3.org/2001/XMLSchema#string

Xiaoli Fan

http://www.w3.org/2001/XMLSchema#string

Yan Ran

http://www.w3.org/2001/XMLSchema#string

Yan Xiong

http://www.w3.org/2001/XMLSchema#string

Yi Zhang

http://www.w3.org/2001/XMLSchema#string

Zhenghua Wang

http://www.w3.org/2001/XMLSchema#string

Zibiao Zhong

http://www.w3.org/2001/XMLSchema#string

P2860

Cell cycle, CDKs and cancer: a changing paradigm

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma

MicroRNAs: target recognition and regulatory functions

AKT/PKB signaling: navigating downstream

Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.

Cyclin D as a therapeutic target in cancer

GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy

miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

P2888

s13277-015-3582-0

P304

8309-8316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-3582-0

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013964206

http://www.w3.org/2001/XMLSchema#string

P698

26002580

http://www.w3.org/2001/XMLSchema#string